The global pharmaceutical industry is a booming enterprise, with a 2015 net worth of nearly $300 billion. Specifically in the drug and medication sector, large corporations are making $1-3.5 billion each year. (1, 2) So who, or what, gets the credit for these growing monetary values? The drug development stage is critical to pharmaceutical success, specifically the process of homogenization, which makes key ingredients for a variety of products. Reliable homogenization in particular is fundamental to the output of high-quality products that consumers will purchase. Below is a compilation of pharmaceutical-related benefits reaped from simply choosing a reliable homogenizer:
Consistent Product Composition
Uniform output is critical for drugs, delivering an even dispersal of ingredients in a given solution, which equates to consistency in active ingredient percentage and product composition. A tight distribution of uniform results reduces manufacturing product waste, driving down costs. Uniform results is touted by many homogenizer producers, but achieved to meet the stringent requirements of high end pharmaceutical drugs only by high quality products.
When surveyed on the attributes most important to them when purchasing a homogenizer, 92% of customers cited durability as #1. Durability is an ability to withstand wear, damage, or pressure; although such a product might cost more upon purchase, it will save more in the long run if it does not need to be replaced as frequently as a lower quality contender. The second most important attribute was low maintenance, ranked as such by 86% of customers. (3)
Fundamental Disease Treatments
The pharmaceutical industry as a whole caters to a plethora of conditions, both chronic and lethal. However, as of 2008, nearly 60% of drug treatments were poorly soluble, which reduces bioavailability. Nanocrystals, which are typically below 100 nm in size, have been shown to be effective in increasing drug bioavailability, and are produced using reliable equipment like the BEE high pressure homogenizer.
Projected Pharmaceutical Industry Growth
Although a variety of factors have contributed to its tidal wave of growth, it is the ability of pharmaceutical products to achieve their specified purpose that hooks customers (both doctors and patients). This buy-in has allowed for evolution of an industry projected to reach $1 billion by 2020. (6) Assuming that the pharmaceutical industry continues on its positive trajectory, opportunities for hiring and laboratory/equipment modernization will increase in frequency.
The BEE High Pressure Homogenizer Advantage
At BEE International, we recognize that the goal for any plant is to increase overall production reliability to maximize output and we know equipment reliability is key to reliable production. Equipment reliability means subsystems and components function as intended without failure for production runs.
That’s why we ensure that our high pressure homogenizers are created with precision and quality engineering. To sustain the reliability of our products, we offer preventative maintenance programs and we provide maintenance guidelines and suggestions for customizations.
With on-site spare part inventory and online spare part inventory, only BEE International’s homogenizers have the ability to take a component off and activate a spare unit so production can continue. We know how much each run is worth to you and we ensure that our homogenizers are ready and easily repairable in the rare case something goes wrong.
If you are in need of a reliable homogenizer, have a look at our high pressure homogenizers. Our products are trusted by pharmaceutical researchers and lab managers around the world for key benefits, such as production of nano/micro emulsions, dispersions, and suspensions; importantly, this equipment can achieve particle sizes at or below 100 nm, a key benefit for researchers & corporations that synthesize pharmaceutical products.
Learn more by visiting http://www.beei.com/industry/pharmaceutical-process-equipment.